Advice
Following a 2nd resubmission
bemiparin (Zibor) is accepted for use within NHS Scotland for the prevention of thromboembolic disease in patients undergoing orthopaedic surgery. Bemiparin was associated with a lower incidence of thromboembolic complications than unfractionated heparin and was non-inferior to another low molecular weight heparin.
Download detailed advice89KB (PDF)
Medicine details
- Medicine name:
- bemiparin 3,500 IU in 0.2ml solution for injection in prefilled syringes (Zibor)
- SMC ID:
- 204/05
- Indication:
- For the prevention of thromboembolic disease in patients undergoing orthopaedic surgery
- Pharmaceutical company
- Archimedes Pharma UK Ltd
- BNF chapter
- Cardiovascular system
- Submission type
- Resubmission
- Status
- Accepted
- Date advice published
- 07 December 2009